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Abstract
Purpose: The Cre-loxP system has become an important strategy for conditional gene deletion
and conditional gene expression in genetically engineered mice. To evaluate Cre recombinase
expression, we generated reporter mice that permit both noninvasive imaging in living animals
and either ex vivo histochemical/immunohistochemical tissue transgene expression analysis or
quantitative enzyme analysis in the same animal.
Procedures: Transgenic reporter mice were generated in which a loxP-flanked enhanced green
fluorescent protein (EGFP) reporter gene and STOP sequence are placed after the nearly
ubiquitously expressed CAG promoter, but before a bicistronic transcriptional unit containing
luciferase and β-galactosidase reporter gene coding sequences.
Results: After global deletion of the floxed STOP sequence by germ line Cre deletion, the
reporter mouse expresses luciferase and β-galactosidase in all tissues examined. Tissue-
specific expression of both reporter genes occurs in reporter mouse strains expressing Cre in
skin (K14 keratin Cre), heart (myosin light chair Cre), or colon (Villin Cre).
Conclusion: The luc-gal
Tg reporter mouse allows noninvasive imaging of target Cre activation
both in living animals and in tissues and cells following necropsy, using loss of EGFP
expression, gain of luciferase expression, and gain of β-galactosidase expression as
alternatives within the same animal for qualitative analysis of Cre expression.
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Introduction
T
he Cre-loxP targeted recombination system has been
widely used for conditional control of gene expression
[1, 2]. Cre recombinase mediates recombination excision of
DNA sequences between its target loxP sites, resulting in the
deletion of target sequences in the genome. Appropriate
conditional gene alterations using the Cre-loxP system
depend on well-characterized and defined Cre expression in
targeted cells. Therefore, evaluation of the pattern of Cre
expression is important both in achieving the targeted genetic
alteration and in avoiding (or at least being aware of)
undesired Cre-mediated recombination events. To facilitate
the evaluation of Cre-targeted recombination, a number of
Cre reporter mouse lines have been developed to determine
the pattern of Cre expression in vivo. In these lines, Cre
expression patterns can be visualized by reporter genes whose
expression is activated only after Cre recombinase-mediated
gene remodeling. A variety of reporter genes have been used
for this purpose, including enzymes that employ colorimetric
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[3–6], fluorescent proteins [7–14], and enzymes that produce
bioluminescent products [15, 16].
Recently, molecular imaging has emerged as a powerful
method to analyze noninvasively gene expression in animal
models [17]. Luciferases have been used as bioluminescent
reporter genes whose activities can be monitored in living
animals by using sensitive charged-coupled device cameras
[18]. There has been extensive and burgeoning use of
noninvasive, repeated monitoring of luciferase reporter
gene expression in living animals, including the monitoring
of Cre expression [15, 16]. However, one potential dis-
advantage of luciferase as a reporter gene is the lack of
resolution of its expression pattern at the cellular level. It is
difficult to obtain reliable expression patterns with the
commercially available anti-luciferase antibodies. To address
this problem, we prepared a bicistronic construct with the
firefly luciferase and β-galactosidase (lacZ) reporter genes,
using an internal ribosomal entry site (IRES), and generated a
reporter mouse line, luc-gal
Tg, using the strong and widely
expressed CAG promoter. In this study, we characterized the
bicistronic reporter mouse line by crossing it with both
ubiquitous and tissue-specific Cre-expressing murine lines
and analyzing luciferase expression in vivo and in necropsy
samples and β-galactosidase expression in necropsy samples.
Materials and Methods
Generation of Cre Reporter luc-gal
Tg Transgenic
Mice
The vector constructed to generate the Cre reporter mouse (Fig. 1a)
includes a CAG promoter [19], loxP sites that flank both the coding
region for enhanced green fluorescent protein (EGFP, Clontech,
Palo Alto, CA, USA) and a transcriptional/translational STOP
sequence (GIBCO, Carlsbad, CA, USA), a transcription unit
containing the coding region of firefly luciferase (Promega,
Madison, WI, USA), and the coding region of Escherichia coli
β-galactosidase. The two reporter gene coding sequences are linked
by the encephalomyocarditis virus (ECMV) IRES (derived from
pIRES2-EGFP Clontech). The entire construct is flanked by
chicken β-globin 5′HS4 insulator elements [20, 21]. The insulator
element was amplified by polymerase chain reaction from chicken
liver genomic DNA by using the following primer sets: HS4F1,
GAG CTC ACG GGG ACA GCC CCC CCC CAA ACG; HS4R1,
AAT ATT CTC ACT GAC TCC GTC CTG GAG TTG. The
plasmid construct was microinjected (transgenic mouse facility, UC
Irvine) into the pronuclei of fertilized eggs of CB6F1 mice.
Founder transgenic mice were selected by genomic Southern
blotting and EGFP expression. Tissue EGFP expression was
examined by using the Maestro in vivo fluorescence imaging
system (CRi Inc., Woburn, MA, USA). For genotyping, the
following primer set amplifying lacZ sequence is used: oIMR0039,
ATC CTC TGC ATG GTC AGG TC; oIMR0040, CGT GGC CTG
ATT CAT TCC. Mice were also genotyped by observing EGFP
expression of either the whole body or tail tip.
Cre-Expressing Mice
The MlcCre mouse was provided by Dr. Yibin Wang (UCLA).
CMVCre (Tg(CMV-cre)1Cgn), K14Cre (Tg(KRT14-cre)1Amc), and
VillinCre (Tg(Vil-cre)997Gum/J) mice were purchased from
Jackson Laboratory (Bar Harbor, MA, USA).
Adenovirus
Ad.CMV.Cre, a nonreplicating adenovirus in which Cre recombi-
nase is under the regulation of the cytomegalovirus (CMV)
promoter, was obtained from Dr. Arnold Berk (UCLA). Ad.
CMV.Cre (1×10
9 pfu in 100 μl phosphate buffered saline (PBS))
was injected into the tail vein of mice.
In vivo and Ex vivo Imaging of Luciferase Activity
For in vivo imaging, mice were anesthetized by intraperitoneal
administration of a ketamine (80 mg/kg, Phoenix Pharmaceutical,
St. Joseph, MO, USA) and xylazine (4 mg/kg, Phoenix Pharma-
Fig. 1. a) The construct used to create the bicistronic Cre reporter mouse. Cre recombinase mediates the recombination of the
two loxP sites flanking the enhanced green fluorescent protein and STOP cassettes, resulting in the expression of luciferase
and lacZ message from the CAG promoter. b) In vivo imaging of luciferase activity following intravenous administration of Ad.
CMV.Cre. The mouse was imaged prior to and 7 days after adenovirus injection. The color overlay on the image illustrates the
photons per second emitted. IRES internal ribosomal entry site, ffLuc firefly luciferase coding region, LacZ β-galactosidase
coding region, pA SV40 polyA.
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with D-luciferin (125 mg/kg; Caliper Life Sciences, Hopkinton,
MA, USA) and placed in the light-tight box of the IVIS 100 optical
imaging system (Caliper Life Sciences). Whole body 1-min images
were acquired repeatedly until the maximum peak of photon
number was confirmed during the 1-min scans. Data at the time
point that gave the highest photon number during 1 min of
scanning time were used for quantification. Collected photon
number and images were analyzed using LIVING IMAGE software
(Caliper Life Sciences).
For ex vivo imaging of isolated tissues, mice were anesthetized
and injected with D-luciferin. After the photon accumulation at 1-
min intervals, examined by in vivo imaging, reached a maximum
level, the mice were sacrificed, and the tissues were rapidly excised.
Tissues were imaged with the IVIS system.
In vitro Luciferase and β-galactosidase Assay
Each tissue was homogenized in passive lysis buffer (Promega).
Lysates were centrifuged, and the supernatants were assayed with
the luciferase assay system (Promega) and β-galactosidase enzyme
assay system (Promega).
LacZ Histochemical Staining
Embryos and tissues were fixed in 4% paraformaldehyde, washed
with PBS, and stained in 0.5 mg/ml X-gal, 5 mM potassium
ferrocyanide, and 5 mM potassium ferricyanide in PBS at 30°C.
LacZ and Luciferase Immunohistochemical
Staining
Embryos were fixed in 4% paraformaldehyde, paraffin-embedded,
and sectioned at 4-μm thickness. LacZ expression was detected
with rabbit polyclonal anti-β-galactosidase antibody (Fitzgerald
Industries International, Concord, MA, USA) and ImmPRESS anti-
rabbit Ig reagent (Vector Laboratories, Burlingame, CA, USA). To
detect luciferase, goat polyclonal antiluciferase (Promega) was
used. Signal was visualized by biotinylated rabbit anti-goat IgG and
the ABC reagent kit (Vector laboratories).
Results
To monitor Cre expression patterns in vivo, we constructed a
transgenic mouse line in which a loxP-EGFP-STOP-loxP
cassette was placed between a strong, nearly ubiquitous CAG
promoter and a bicistronic reporter gene cassette (Fig. 1a).
The firefly luciferase and lacZ reporter genes were used in the
bicistronictranscriptionalunit,connected byan ECMVIRES,
to facilitate both noninvasive (luciferase) and ex vivo
histologic (β-galactosidase) examination. The entire trans-
gene is flanked by tandem copies of the chicken β-globin 5′
HS4 insulator elements, to reduce chromosomal positional
effects on gene expression [20, 21]. Transgenic mice were
generated by pronuclear injection, and founder lines were
selected by genomic Southern blotting and EGFP expression
of various tissues. Two founder lines that demonstrated
widespread, nearly ubiquitous EGFP expression from the
CAG promoter (Fig. 2) were further analyzed for luciferase
expression following intravenous injection of Ad.CMV.Cre,
an adenovirus that expresses Cre recombinase from the
human CMV minimal promoter. Systemically administered
adenovirus overwhelmingly infects liver [22, 23]. Both
founder lines showed significantluciferase hepatic expression
7 days after Ad.CMV.Cre administration, when assayed
noninvasively for luciferase expression (Fig. 1b). For sub-
sequent experiments, we used the founder line that shows
both greater luciferase activity and lower basal expression.
Mice transgenic for the Cre recombinase gene driven by a
CMV promoter have previously been reported to express
Cre in the germ line, as well as in nearly all tissues [24]. To
examine consequences of germ line Cre expression and
consequent global deletion of the floxed STOP sequence in
various tissues of our reporter mouse by noninvasive
luciferase bioluminescence, β-galactosidase histochemistry,
and quantitative in vitro luciferase and β-galactosidase
enzymatic activity, the bicistronic luc-gal
Tg reporter mouse
was crossed with a CMVCre transgenic mouse. The double
transgenic mouse was generated and then crossed with a wild-
type mouse, to obtain luc-gal
Tg(del) mice in which the EGFP/
STOP sequence is excised from all cells. The luc-gal
Tg(del)
mice were examined initially for CAG-directed luciferase
expression by noninvasive bioluminescent in vivo imaging
(Fig. 3a). Because the pigmented hair of the mouse attenuates
the bioluminescent signal from the murine tissues and organs,
portions of the mouse body were shaved. After luciferin
injection, strong luciferase signal is detectable from shaved
areas of both the dorsal and ventral surfaces of the mouse.
Luc-gal
Tg(del) mice, in which the EGFP-STOP sequence
between the CAG promoter and the bicistronic reporter gene
transcription unit was deleted in all cells, were then sacrificed,
and organs were removed, and luciferin-dependent biolumi-
nescence was imaged (Fig. 3b). Extracts were then prepared
from the various tissues of the luc-gal
Tg(del) mice, and
luciferase and β-galactosidase enzymatic activities were
quantitatively assayed in the tissue lysates. Luciferase and β-
galactosidase activities are observed in all tissues examined
(Fig. 3c, d). The level of luciferase activity and the level of β-
galactosidase activity from the CAG promoter vary substan-
tially in the various murine tissues (Fig. 3c, d). However, these
data demonstrate that both the noninvasive luciferase reporter
and the conventional in vitro β-galactosidase reporter can
indicate Cre recombinase activity in essentially all tissues.
Although substantial increases in the level of activity for
both reporters can be detected in all tissues, the ratio of
luciferase activity to β-galactosidase activity in tissue
extracts is strikingly different in the various murine tissues
(Fig. 3e). The potential reasons for these differences in
luciferase/β-galactosidase ratios and their implications for
use of transgenic reporter mice are considered more
extensively in the “Discussion” section.
286 T. Ishikawa and H. R. Herschman: Noninvasive and Ex vivo Cre Reporter MouseTo demonstrate the utility of the lacZ reporter gene in
analyzing tissue-specific expression, 10.5-day embryos derived
from luc-gal
Tg(del) and wild-type mice were stained for β-
galactosidase activity as whole mounts (Fig. 3f). Embryos which
have a Cre-activated reporter gene cassette show the character-
istic blue color associated with β-galactosidase activity. In
contrast, control embryos do not show any basal staining.
Finally, to demonstrate the advantage of having both
luciferase and β-galactosidase as markers, sections of
embryos from Luc-gal
Tg(del) and wild-type littermate mice
were stained with either anti-β-galactosidase antibody or
anti-luciferase antibody. While robust staining was confined
to the luc-gal
Tg(del) embryo using anti-β-galactosidase anti-
body, we were unable to obtain specific staining with anti-
luciferase antibody (Fig. 4).
To determine whether the luc-gal
Tg reporter line is
suitable for detection of tissue-restricted Cre recombinase
activity, luc-gal
Tg transgenic mice were crossed with a series
of mice that express Cre recombinase from different
promoters. The luc-gal
Tg reporter mouse was first crossed
with a MlcCre knock-in mouse in which Cre is under the
control of the cardiac-specific myosin light chain 2v




Cre/+), strong luciferase signal is detected
exclusively from the chest region by in vivo imaging
(Fig. 5a). In contrast, no luciferase activity is detected from
the luc-gal
Tg littermate control that contains the bicistronic
reporter gene, but not the gene for Mlc-driven Cre
recombinase. After peak overall bioluminescence was
observed, the double transgenic luc-gal
Tg/Mlc
Cre/+ mouse
and control single transgenic luc-gal
Tg reporter mouse were
sacrificed, and organs were removed and imaged (Fig. 5b).
Ex vivo luciferase imaging confirms that the bioluminescent
signal seen in the noninvasive imaging of the living luc-gal
Tg/
Fig. 2. Enhanced green fluorescent protein fluorescence from organs and tissues from the control wild-type littermate mouse
(left or lower sample in each photo) and from the luc-gal
Tg transgenic mouse (right or upper sample in each photo). Tissues
were imaged in the Maestro imaging instrument, and specific signal was extracted by Maestro imaging software.
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Cre/+ mouse (Fig. 5a) is from the heart (Fig. 5b). No
luciferase signal could be detected from any other organ.
When isolated hearts were subsequently stained for β-
galactosidase activity (Fig. 5c), only luc-gal
Tg/Mlc
Cre/+
double transgenic hearts are stained.
The luc-gal
Tg mouse was next crossed with a K14Cre
transgenic mouse. Cre is expressed from the skin epithelial
cell-specific keratin 14 promoter in the K14Cre transgenic
mouse [26]. In the doubly transgenic luc-gal
Tg/K14Cre
Tg
mouse, luciferase signal is detected on all shaved surfaces of
the living animal when analyzed by noninvasive biolumi-
nescent imaging (Fig. 6a). Ex vivo bioluminescent imaging
of isolated tissues and organs shows that the signal observed
by imaging of the living luc-gal
Tg/K14Cre
Tg mouse (Fig. 6a)
is derived only from skin, and not from internal organs
(Fig. 6b). Skin from the luc-gal
Tg/K14Cre
Tg mouse was also
positive for β-galactosidase activity (Fig. 6c).
Finally, the luc-gal
Tg mouse was crossed with a VillinCre
transgenic mouse. Cre is expressed from the 12.4-kb region
of the mouse Villin promoter in the VillinCre transgenic
mouse. This mouse is reported to express Cre at high levels
within the entire intestinal epithelium [27]. In the doubly
transgenic luc-gal
Tg/VillinCre
Tg mouse, luciferase signal is
detected in the abdominal region of the living animal by in
vivo imaging, using the IVIS noninvasive optical imaging
system (Fig. 7a). Ex vivo optical imaging of isolated organs
confirms that the bioluminescence observed in the living
luc-gal
Tg/VillinCre
Tg animal (Fig. 7a) is derived from
luciferase expression in the intestine (Fig. 7b). A closer
look at the opened colon demonstrates regions of differing
Fig. 3. Reporter gene expression from luc-gal
Tg(del) mice, in which the STOP cassette has been deleted by germline
expression of Cre driven by the cytomegalovirus promoter. a) In vivo luciferase imaging. Photos and the color overlays
illustrating the photon number are shown for dorsal and ventral images. Note that part of the mouse body is shaved. b) Ex vivo
images of luciferase expression in tissues from same mouse shown in (a). c) Luciferase activity in individual tissues measured
by in vitro luciferase assay of tissue extracts from luc-gal
Tg(del) mice. d) β-galactosidase activity in individual tissues measured
by in vitro β-galactosidase enzyme assay of the same tissue extracts used in (b). e) Ratio of luciferase/β-galactosidase activity
for individual tissues in luc-gal
Tg(del) mice. f) Whole mount staining for β-galactosidase activity of embryos derived from crossing
between double transgenic and wild-type mice. The upper row shows embryos containing the luc-gal
Tg(del) transgene; the lower
row shows embryos without the transgene.
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no luciferase activity is detectable by bioluminescent
imaging of the opened colon of the luc-gal
Tg littermate
mouse in which Cre recombinase is not expressed. Moderate
luciferase activity is also detected in testis (Fig. 7b), con-
sistent with the report of villin expression in seminiferous
ducts [28]. Significant β-galactosidase activity is also
observed in the luc-gal
Tg/VillinCre
Tg double transgenic
mouse intestine, but not in the intestine of the luc-gal
Tg
littermate that does not express the VillinCre transgene
(Fig. 7d).
Discussion
In this study, we generated a reporter mouse line in which
the luciferase and lacZ reporter gene coding regions are
tandemly expressed in a bicistronic complex only when Cre
recombinase has removed a STOP sequence between the
CAG promoter and the reporter gene coding regions. The
CAG promoter is an artificial, chimeric promoter that
includes portions of the chicken β-actin promoter and the
CMV immediate early enhancer [19]. This promoter is
highly active in a wide range of cell types; transgenic mice
expressing EGFP from the CAG promoter are reported to
show ubiquitous expression and were referred to as “green
mice” [29]. Because the luc-gal
Tg reporter mouse described
here also has the EGFP reporter gene coding region adjacent
to the CAG promoter, we can compare global CAG
promoter activity of our mouse to that of the “green mice”
originally described by Okabe et al. [29]. Like the original
“green mice,” we find that essentially all tissues in luc-gal
Tg
mice express the EGFP reporter gene from the CAG
promoter.
By placing EGFP proximal to the STOP sequence, we
have created a mouse in which all tissues can be imaged with
EGFP. The penetrance of Cre excision can be estimated, at
both the tissue and cellular level, by loss of EGFP expression.
Because the luciferase and β-galactosidase reporters are
placed distal to the floxed region of the luc-gal
Tg transgene,
selected tissues can be imaged following tissue-specific
Cre recombinase deletion of the STOP sequence. Thus, the
luc-gal
Tg mouse provides a very flexible reporter mouse
from which any tissue or cell expressing the EGFP reporter
gene can be isolated and subsequently monitored, either in
culture or following transplantation. Moreover, by subse-
quently introducing Cre recombinase into the luc-gal
Tg cells,
a reporter gene that permits more quantitative in vivo
evaluation (luciferase), reporter genes that permit more
quantitative evaluation in cell extracts (luciferase and β-
galactosidase) and a reporter gene that provides simpler,
more sensitive and reliable histochemistry and immunohis-
tochemistry (β-galactosidase) are expressed. The combina-
tion of three reporters in the luc-gal
Tg mouse gives this
system multiple alternatives to evaluate Cre expression.
To verify ubiquitous expression of luciferase and β-
galactosidase in all tissues from the CAG promoter, the
loxP-flanked STOP sequence was removed from all cells by
deleting the STOP sequence in the germ line and analyzing
the progeny for luciferase and β-galactosidase activity. All
organs in the resulting luc-gal
Tg(del) mouse exhibit elevated
Fig. 4. Immunohistochemical staining of luc-gal
Tg(del) (upper
panels) and wild-type littermate (lower panels)e m b r y o
paraffin sections with anti-β-galactosidase (left panels) and
antiluciferase (right panels) antibodies. A portion of the head
region is shown in each section.
Fig. 5. a) In vivo imaging of the luc-gal
Tg transgenic/MlcCre knock-in (luc-gal
Tg; Mlc
Cre/+) mouse and the control luc-gal
Tg
reporter mouse (luc-gal
Tg). b) Ex vivo images of luciferase expression in tissues from the same mice shown in (a). c) Whole
mount staining for β-galactosidase activity of hearts from mice shown in (a) and (b).
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the luc-gal
Tg mouse (in which the floxed STOP sequence
has not been eliminated). However, the level of luciferase
expression varies over four orders of magnitude among
different organs. Luciferase activity is highest in heart and
muscle and lower in intestine and liver, an organ expression
profile similar to that of CAG-driven EGFP in the transgenic
mouse described by Hadjantonakis et al. [30]. We think
these differences in luciferase tissue expression are likely to
be due to differences in the efficacy of the CAG promoter in
various tissues, rather than to chromosomal positional effects
from the transgene integration site, since we flanked the
transgene reporter construct by insulator sequences to reduce
the effect of integration sites. The ability to quantify
accurately the levels of luciferase enzyme activity in tissue
extracts and compare these results with the semiquantitative
data obtainable with EGFP fluorescence, histochemistry, or
western blotting illustrates the flexibility and advantages of
the three reporter luc-gal
Tg mouse.
The luciferase reporter provides a sensitive signal with a
wide dynamic range and low background. Particularly in its
application as a Cre reporter mouse, this combination of
luciferase traits—sensitive and semiquantitative analysis in
vivo in living animals and excised tissues as well as sensitive
and easily quantifiable analysis in extracts—provides an
excellent means to establish the qualitative and quantitative
degree of Cre excision in in vivo/in vitro experiments.
Confirmation of tissue specificity is, of course, important in
characterization of murine Cre lines. As cell-specific Cre
transgenic and knock-in mouse lines become increasingly
available, careful and thorough characterization of the
specificity—or lack thereof—of Cre expression becomes
increasingly important. Luciferase expression after Cre
excision in the luc-gal
Tg mouse is strong enough to be seen
clearly by ex vivo imaging even if the Cre expression takes
place in only a part of the organ, e.g., VillinCre expression
in seminiferous ducts [28]. This strategy should be useful in
identifying previously undiscovered promoter activities in
unexpected tissues and will be increasingly valuable as
additional Cre knock-in strains, in which Cre expression
should more accurately reflect the promoter activity of the
targeted gene, are developed.
The luciferase reporter has a major advantage over
fluorescent reporter proteins; although fluorescent proteins





Tg) mouse and the con-
trol luc-gal
Tg reporter mouse (luc-gal
Tg). Dorsal and ventral
images are shown. Note that part of the mouse body is
shaved. b) Ex vivo image of luciferase expression in tissues
of double transgenic mouse shown in (a). c) Whole mount
staining for β-galactosidase activity of skin from double
transgenic mouse (luc-gal
Tg; K14Cre
Tg) and control mouse
(luc-gal
Tg).





Tg) mouse and the con-
trol luc-gal
Tg reporter mouse (luc-gal
Tg). b) Ex vivo image of
luciferase expression in tissues of the luc-gal
Tg/VillinCre
Tg
double transgenic mouse shown in (a). c) Ex vivo images of
luciferase expression in opened colons of the luc-gal
Tg/
VillinCre




Tg reporter mouse (luc-gal
Tg) shown in (a).
d) Whole mount staining for β-galactosidase activity of





Tg) mouse and a control luc-
gal
Tg reporter (luc-gal
Tg)m o u s e .
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the reporter gene signal from tissue autofluorescence, par-
ticularly from internal organs. While both bioluminescent
proteins such as luciferase and fluorescent proteins such as
EGFP suffer from scattering and absorption that reduce their
resolution and sensitivity in vivo, luciferase measurements are
not compromised by endogenous light emission. Thus,
detection of specific signals from internal organs such as heart
and intestine is more easily accomplished with the luciferase
reporter. Luciferase imaging in the luc-gal
Tg mouse may also
provide some opportunities for longitudinal monitoring of cell
lineage and cell movement in living animals, in addition to the
evaluation of the specificity of Cre recombinase expression.
For more quantitative in vivo imaging in living animals,
reporter genes that use technologies such as positron emission
tomography need to be employed [31–33].
The major disadvantage of luciferase as a reporter gene is
at the cellular level. Antisera that provide reliable, easy, and
reproducible immunohistochemistry for luciferase are not
available. We have compensated for this deficiency by
utilizing lacZ, another reporter gene, in tandem with
luciferase to monitor tissue-specific Cre recombinase activity
at the organ, tissue, and cellular level by histochemical and
immunohistochemical detection methods, both on sections
and on whole mount samples. Although reports of immuno-
histochemical detection of luciferase activity following
injection of luciferase-encoding plasmids into tissues do
exist [34, 35], we find that the far more robust immunohis-
tochemistry methods available for β-galactosidase [36, 37]
make cellular analysis of transgene expression much simpler
to interpret.
Although the same luciferase/ECMV IRES/β-gal tran-
script is expressed in all tissues of the luc-gal
Tg mouse
following Cre recombinase removal of the STOP sequence,
the luc/β-galactosidase activity ratio varies quite substan-
tially among different organs. At least three possibilities
exist to explain this variability: (1) There may exist codons
in these non-mammalian proteins that are translated more
effectively in one cell type relative to another, e.g., as a
result of different tRNA expression levels in different
tissues. (2) Efficacy of assembly of the β-galactosidase
tetramer may differ from tissue to tissue. (3) The more likely
explanation for the difference in the luc/β-galactosidase ratio
in different tissues is a tissue-specific difference in the
ability of various cell types to initiate translation from the β-
galactosidase coding unit distal to the IRES. Although the
location of the β-galactosidase coding unit distal to the IRES
undoubtedly reduces the sensitivity of this reporter gene, the
well-characterized, sensitive, robust, and widely used in
vitro enzyme activity assays, histochemical assays, and
immunohistochemistry reagents and protocols for β-galacto-
sidase [36, 37] suggest that this compromise will not be a
practical impediment to employing the various β-galactosi-
dase reporter modalities of the luc-gal
Tg mouse. Indeed, this
mouse may serve as a useful tool in understanding the
properties and functions of IRES.
Avarietyofmouse reporterlinestomonitor Creactivityhas
beengeneratedpreviously.Eachlinecontainsdifferentreporter
genes and has consequent advantages and disadvantages.
The luc-gal
Tg reporter mouse, with EGFP, luciferase, and
β-galactosidase reporter genes that can be used in various
combinations and applications, should provide an additional
valuable and useful mouse with which to evaluate Cre
recombinase activity and to monitor cell engraftment, prolif-
eration,movement,anddifferentiationina numberofcontexts.
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